EXTENSIVE STAGE SMALL CELL LUNG CANCER
Clinical trials for EXTENSIVE STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat lung cancer?
Disease control TerminatedThis study tested a new drug called hSTC810 combined with a standard chemotherapy (paclitaxel) for people with advanced small cell lung cancer that had returned or stopped responding to prior treatment. The goal was to see if this combination was safe and could help control the c…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: STCube, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Trial halted: testing combo to hold back aggressive lung cancer
Disease control TerminatedThis study tested whether adding a drug called vorolanib to an immunotherapy drug (atezolizumab) could help keep extensive-stage small cell lung cancer from getting worse for a longer time after patients finished standard chemotherapy. It was a Phase 2 trial that enrolled 11 adul…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC